SCHEMBL13264167

SCHEMBL13264167

Bc1ccc2[nH]c(C(C)(C)C)nc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.45
▸ L3MBTL1 Q9Y468 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ SCN10A Q9Y5Y9 2/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ PDE1A P54750 1/20 0.38
▸ PDE1B Q01064 1/20 0.38
▸ PDE1C Q14123 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ MAPT P10636 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ TXN P10599 1/20 0.33
▸ PDE2A O00408 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23619188 0.81 ALDH1A1 (0.47) ALDH1A1L3MBTL1SMN1; SMN2SCN10AKCNH2
SCHEMBL10005347 0.80 ALDH1A1 (0.46) ALDH1A1L3MBTL1SMN1; SMN2SCN10AKCNH2
SCHEMBL846855 0.80 SCN10A (0.58) ALDH1A1L3MBTL1SMN1; SMN2SCN10AKCNH2
SCHEMBL7028984 0.79 KDM4E (0.50) ALDH1A1L3MBTL1SMN1; SMN2SCN10AKCNH2
SCHEMBL14491782 0.79 ALDH1A1 (0.45) ALDH1A1L3MBTL1SMN1; SMN2SCN10AKCNH2
SCHEMBL2732982 0.79 ALDH1A1 (0.45) ALDH1A1L3MBTL1SMN1; SMN2SCN10AKCNH2
SCHEMBL10248397 0.79 SMN1; SMN2 (0.45) ALDH1A1L3MBTL1SMN1; SMN2SCN10AKCNH2
SCHEMBL846648 0.77 KDM4E (0.56) ALDH1A1L3MBTL1SMN1; SMN2SCN10AKCNH2
SCHEMBL5988285 0.76 SMN1; SMN2 (0.43) ALDH1A1L3MBTL1SMN1; SMN2SCN10AKCNH2
SCHEMBL868599 0.76 SMN1; SMN2 (0.43) ALDH1A1L3MBTL1SMN1; SMN2SCN10AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010084767-A1 N-SUBSTITUTED SATURATED HETEROCYCLIC SULFONE COMPOUNDS WITH CB2 RECEPTOR AGONISTIC ACTIVITY RAQUALIA PHARMA INC. (JP) 2010-07-29 — — WO disclosed
Send feedback